A US psychiatrist is proposing a new sub-specialty -- psychocardiology -- to diagnose and treat patients who suffer both depression and heart disease. Dr Angelos Halaris of the Loyola University Medical Center near Chicago said 40 percent to 60 percent of heart disease patients suffer clinical depression and 30 percent to 50 percent of patients who suffer clinical depression were at risk of developing cardiovascular disease. The body's immune system fights stress as it would fight a disease or infection. The immune system produces proteins cytokines, including interleukin-6. Initially, this inflammatory response protects against stress, but over time, a chronic inflammatory response can lead to arteriosclerosis -- hardening of the arteries -- and cardiovascular disease. It's a vicious cycle: depression triggers a chronic inflammation, which leads to heart disease, which causes depression, which leads to more heart disease, Halaris said. In his most recent study, Halaris and colleagues found that an inflammatory biomarker, interleukin-6, was significantly higher in the blood of 48 patients diagnosed with major depression than it was in 20 healthy controls. Halaris presented the findings at a joint congress of the World Psychiatric Association and International Neuropsychiatric Association in Athens. At the congress, Halaris formally proposed creation of a new psychocardiology sub-specialty.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor